Therapy Market Research Reports & Industry Analysis

... needs pertinent to COPD treatment, thereby propelling the demand for oxygen therapy market Home Healthcare is anticipated to grow lucratively at CAGR of 11.8% owing to associated benefits ...

... . Proton treatment, likewise called proton beam treatment, is a kind of radiation treatment that uses protons instead of x-beams to treat disease. It is ... tissue and basic structures untouched. This report assesses the global radiation therapy market alongwith major regional markets. The top companies having a ...

... of gene therapy for the treatment of incurable diseases, such as diabetes, cancer, and HIV amongst others. According to RNCOS’ new research report “Global Gene Therapy Market Forecast to 2020”, most of the gene therapy researches are being focused on finding the treatment for ...

... RNCOS in “Global Sleep Apnea Market Outlook 2020” report, the global sleep apnea therapeutic devices market is anticipated to grow at a CAGR of 7.5% during the forecast period (2015-2020). The market growth is expected ... of sleep apnea; however, central sleep apnea has an increasing incidence in patients with heart diseases. In terms of geography, North America is the largest market forsleep apnea therapeutic devices market ...

... expanded the application of proton therapy to almost every site of the human body . Proton therapy market is mainly centred ... proton therapy and thus, many new proton centers are adapting it worldwide. This report assesses the proton therapy market and associated terms in terms of both market volume and market ...

... report titled “Global proton therapy Market: Trends & Opportunities (2015 Edition)” provides an in-depth analysis of the global proton therapy market with detailed analysis of market sizing and patients treated by proton therapy. The report also provides detailed market share analysis of the global proton therapy market by regions ...

... , Global Proton Therapy System Market Forecast and Analysis 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Proton Therapy System market collected ... provides a clear insight into the market share analysis of key industry players. The major players in the global Proton Therapy System market areVarian, IBA, Hitachi, Mevion ...

... , Global Proton Therapy Systems Market Forecast and Analysis 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Proton Therapy Systems market collected ... provides a clear insight into the market share analysis of key industry players. The major players in the global Proton Therapy Systems market areVarian (USA), Mevion (USA ...

... have now started investing in proton therapy to make it more accessible to patients. According to the “China Proton Therapy Outlook 2020” report by RNCOS, by 2020, China will have nine proton therapy centers. Consequently, the market will attain revenue of around US$ 165 Million by 2020, growing at a CAGR ...

... investing in proton therapy to make it more accessible to the colossal pool of cancer patients. According to the “Japan Proton Therapy Outlook 2020” report by RNCOS, by 2020, there will be 13 operational proton therapy centers in Japan. Consequently, the market will attain revenue of around US$ 150 Million by 2020, growing at a CAGR ...

... of proton therapy centers. Hence, many research institutions and hospitals have now started investing in proton therapy to make it more accessible to patients. According to the “South Korea Proton Therapy Outlook 2020” report by RNCOS, by 2020, South Korea will have two proton therapy centers. Consequently, the ...

... report titled “Global Allergy Immunotherapy Market: Trends & Opportunities (2015-2019)” provides an in-depth analysis of the global allergy immunotherapy market with detailed analysis of market sizing and growth, market share and economic ... allergy disease. The report provides detailed market share analysis of the global allergy immunotherapy market by types, regions and players. The market share of allergy immunotherapy market in the respiratory market and prescription allergy market ...

... likely to propel the market growth. According to our new research report, “Global Protein Therapeutics Market Outlook 2020”, a large number of existing and new market players are rigorously ... global protein therapeutics market, and projects the market during the period 2013-2020. Some of the key aspects included in the report are the market share ...

... pending approvals, may enter the market to boost the growth. According to RNCOS’ new research report “Global Gene Therapy Market Outlook 2020”, a major focus has been ... a view to understanding the competitive landscape, the profiles of key market players have been included in the report to present a complete picture of the global gene therapy market.

... number of proton therapy centers. Hence, many research institutions and hospitals have started investing in proton therapy to make it more accessible to patients. According to the “US Proton Therapy Market Outlook 2020”, report by RNCOS, the United States will be home to 29 such centers by 2020. Consequently, the market will ...

Global Radiotherapy Market is estimated to be $6.1 billion in 2014 with CAGR of 6.65% is expected to reach $10.2 billion by 2022. The global radiotherapy market is a widely growing sector in recent years and is driven by factors such as increasing number of cancer patients and untapped market in some ...

... of Stem Cells in Cell Therapy Global Cell Therapy Market Analysis Global Cell Therapy Clinical Pipeline by Country, Indication & Phase Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication Global Cell Therapy Clinical Pipeline: 262 Cell Therapies Marketed Cell Therapies: 13 Marketed Cell ...

... generic Copaxone may cause some healthcare providers in the US to promote injectable therapies over more expensive oral alternatives. This week's FirstWord Physician Views poll will ask US-based neurologists: What percentage of Copaxone patients they anticipate switching to a three-times ...

... status – will be presented at next year's ASCO meeting. To gain better physician insight on the potential future role of these two therapies, FirstWord ... ahead of current EGFR therapies such as Tarceva based on current data? What progression-free survival (PFS) benefit CO-1686 would have to demonstrate ...

... Oncogene Inhibitors Pipeline: 185 Drugs Majority Oncogene Inhibitors in Preclinical Phase: 105 Drugs Proto Oncogene Protein c met Inhibitors Pipeline: 42 Drugs Proto Oncogene Protein c-akt Inhibitors: 39 Drugs Marketed Oncogene Inhibitors: 22 Drugs Marketed Proto-Oncogene Protein c-bcl-2 Inhibitors: 8 Drugs ...

... of uptake, particularly as many KOLs expected Pfizer's drug to be priced lower. What does the performance and positioning of Xeljanz mean for other ... do you think will be necessary to drive adoption of baricitinib in favour of Xeljanz? What impact do you think availability of a cheaper, once-daily oral treatment ...

... safety issues first emerged? To gain better understanding about the views of doctors on the potential of gene therapy, FirstWord PLUS is polling US- and ... launched in Germany at a price of more than 1 million euros ($1.1 million). How concerned are you that gene therapies like this may prove cost ...

2014 Sales of Recombinant Therapeutic Antibodies & Proteins This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2014. Sales data were obtained from company publications ...

... Engineered TCR and CAR Immunotherapeutics 2015: A comparative analysis of the landscape of and business opportunities with  TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The engineered ... Cellular TCR T Cells CAR T Cells (autologous/allogeneic) Recombinant Bispecific TCR-anti-CD3 (e.g. ImmTACs) Bispecific antibodies (incl. anti-CD3) This report Engineered TCR and CAR Immunotherapeutics ...

... characteristics for an ideal NASH therapy, as based on KOL feedback. This Physician Views poll uses that summary as inspiration and asks US and EU5 ...

... size ... Peptide & Insulin “Global Peptide Therapeutics Pipeline Insight 2015” Report Highlights: Global Peptide Therapeutics Market Overview Global Peptide Therapeutics Pipeline By Peptide Type Global Peptide Therapeutics Pipeline By Company, Indication & Phase Peptide Therapeutics Clinical Pipeline: 743 Peptides ...

Innovative Therapies for treating diseases ... interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being ... coverage in our Outlook this year. Key Criteria for Our Selection are:- Uniqueness of the Technology platform and the ability ...

... titled “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the acne market with focus on global prescription drugs. The report assesses the market sizing ... laser treatment for acne, technology driven products are the key trends of the acne industry. However, with immense growth opportunities, the global acne market faces the ...

... of novel delivery technologies employed in the formulation of abuse deterrent product, technologies employed in enhancing patient compliances and emerging novel mechanisms in the management of pain. Renewed interest on pain therapy ...

... Proton Therapy Market Opportunity Analysis” Report Highlight: US Proton Therapy Market Overview Targeted Patient Base & Economic Capacity Analysis Proton Therapy Cost Analysis Proton Therapy Reimbursement Policy Proton Therapy Center Infrastructure Analysis US Proton Therapy Market ...

Peptide Therapeutics Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each ...

... a comprehensive assessment of the fast–evolving, high–growth of United States Pain Management Therapeutics Sector. This 73 page report with 46 Figures and ... the basis of: I. United States Pain Management Therapeutics Market from the year 2005 – 2018 II. United States Pain Management Patients Population from ...

... ? Multiple Sclerosis – Oral therapy takes centre stage is a comprehensive Therapy Trends report packed with knowledgeable opinions and insights of 12 leading US and European KOLs on current ... , MD, is a preeminent MS clinician at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Co-Director, Multiple Sclerosis Care Center, Maimonides Medical Center Dr Robert Naismith, MD, Assistant Professor ...

... Gene Therapy to Cancer Treatment Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook FDA & AMA Guidelines for Gene Therapy Gene Therapy Pipeline by Phase, Indications, Country & Company Gene Therapy Pipeline: 246 Drugs Marketed Gene Therapy: 2 (Gendicine & Rexin-G) Cancer Gene Therapy Pipeline ...

... can be prevented. “UAE IVF Treatment Market Outlook 2018” Report Highlights: Current Market Scenario IVF Treatment Market Potential Treatment cycle & Birth Rate Fertility Treatment Loan Facility Regulations for Licensing of Fertilization Centers Medical ...

... make it more accessible to patients. According to the “US Proton Therapy Outlook: Market Opportunities”, by RNCOS, the United States will be home to almost 29 such centers ... size and its future condition. After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which ...

... benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth interviews with 12 leading healthcare payers in the US, is packed with hard-hitting, candid ... been matched by the opposition of healthcare payers at the cost. This report gives insights into what US healthcare payers really think about HCV drug ...

... . “Recombinant Therapeutic Proteins Market & Pipeline Analysis” Report Highlights: Global Market Overview Mechanisms of Recombinant Protein Production Types of Recombinant DNA Technology Clinical Pipeline by Phase, Indication, Company, & Country Marketed Recombinant Therapeutic Protein Drugs ...

The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and ... , various antifungal agents with novel action mechanisms, broader action spectrum and fewer side effects have emerged. Growth within global antifungal therapeutics market is driven ...

... neurologists to ascertain how practising physicians currently view and evaluate the gene therapy development space. Specifically we are asking them... How familiar they are with ... What they perceive to be the key benefits of gene therapy? What are their specific concerns with gene therapy? What is the highest ...

... a biologic therapy? Whether, and to what extent, quality-of-life measures will be more important than secondary efficacy measures for differentiating new biologic therapies for severe asthma? What level of advantage, if any, reduced dosing frequency would provide for a biologic severe asthma ...

... centers that have been established globally. According to our report, “Global Proton Therapy Outlook 2018”, 16 such centers have been established ... capacity of existing centers and those that are expected to come up by 2018. In the Geographic Assessment section, we have provided a detailed analysis of four ...

... titled “Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global aortic aneurysm repair market with major focus on more prevalent endovascular abdominal aortic aneurysm repair. The report also provides detailed analysis of aortic aneurysm market in major regions ...

... for more proton therapy centers are very high. This report is divided into 14 Chapters A. United States Proton Therapy Market – Actual ... IBA Proton Therapy 2. Optivus Proton Therapy 3. Hitachi Proton Therapy 4. Mevion Proton Therapy 5. Varian Proton Therapy Chapter No. 11 speaks of Proton Therapy centers ...

... threatening diseases. “Global Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: Introduction to Cell therapy Global Cell Therapy Market Overview Global Cell Therapy Market Dynamics Cell Therapy Pipeline by Phase, Country & Target Indications Cell Therapy Drugs in Pipeline: More ...

... and in industry. Since discovery, RNA interference is considered to be a turning point for molecular ... Global RNAi Therapy Report Highlights: Introduction & Need Analysis of RNAi Therapy Benefits & Drug Delivery Mechanics Related to RNAi RNAi Therapy Market Insight Ongoing Clinical Trail/Pipeline for RNAi ...

There are more than 1400 sustained or controlled release drugs have been approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of overall ...

Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded ... OTEZLA – apremilast, Xeljanz – tofacitinib) and onwards. In this report, we highlight the novel targets – oral, injectables, and topical drugs in the pipeline for the treatment of Psoriasis ...

... decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs – Thalomid (thalidomide) and Revlimid (lenalidomide) have become the cornerstone of treatment for patients with Multiple Myeloma (MM) resulting ...

... map for biosimilars space, at this time we see Sandoz, JCR, Meiji Seika Pharma, Fuji Film Kyowa Kirin Biologics, Nippon Kayaku, Nichi Iko, Yoshindo etc. to be amongst the key players in biogenerics business in Japan. It is also noteworthy ...